About Rabia Khan
Rabia Khan, CEO with a PhD in Human Genetics and an MBA, has held influential roles in major biotech firms and is dedicated to promoting diversity in STEM.
Known information
Rabia Khan, born and raised in Pakistan, is a distinguished leader in the biotechnology sector, currently serving as a CEO. She holds a PhD in Human Genetics and an MBA, equipping her with a robust foundation in both scientific and business management. Previously, Khan was the Managing Director of Discovery Sciences at Sensyne Health Plc, where she was instrumental in establishing the company’s scientific strategy, building its data science and discovery teams, and leading pharmaceutical partnerships with major industry players such as Bayer, BMS, Roche, and Alexion. Her career also includes senior positions at BenevolentAI and Meta. Khan is deeply committed to enhancing diversity within the STEM fields. Her efforts and leadership have earned her recognition as one of the 50 Movers and Shakers in BioBusiness and one of the 30 Rising Leaders in Biotech in 2020.
About Serna Bio
Serna Bio, formerly Ladder Therapeutics (LTX), is a biotech company specializing in the development of novel therapeutics targeting the transcriptome for diseases with high unmet medical needs.